Table 4.
80 mmHg | 90 mmHg | 100 mmHg | 120 mmHg | |
---|---|---|---|---|
MAP, mmHg | ||||
Con | 78 ± 3 | 89 ± 2 | 98 ± 1 | 117 ± 1 |
HF | 83 ± 1 | 91 ± 1 | 100 ± 1 | 117 ± 4 |
HF-TR | 81 ± 2 | 92 ± 2 | 99 ± 2 | 116 ± 3 |
HR, beats/min | ||||
Con | 88 ± 3 | 80 ± 6 | 71 ± 4 | 71 ± 8 |
HF† | 104 ± 4* | 98 ± 6 | 99 ± 11 | 109 ± 16* |
HF-TR | 85 ± 6 | 86 ± 6 | 81 ± 6 | 80 ± 7 |
CBF, ml·min−1·g−1 | ||||
Con | 0.27 ± 0.02 | 0.31 ± 0.03 | 0.38 ± 0.04 | 0.58 ± 0.11 |
HF | 0.30 ± 0.07 | 0.30 ± 0.07 | 0.36 ± 0.06 | 0.47 ± 0.11 |
HF-TR | 0.20 ± 0.04 | 0.26 ± 0.06 | 0.28 ± 0.06 | 0.42 ± 0.10 |
MV̇o2, μmol O2·min−1·g−1 | ||||
Con | 1.10 ± 0.06 | 1.36 ± 0.10 | 1.74 ± 0.12 | 1.88 ± 0.21 |
HF | 1.40 ± 0.22 | 1.35 ± 0.29 | 1.67 ± 0.21 | 2.05 ± 0.52 |
HF-TR | 0.84 ± 0.12 | 0.95 ± 0.14 | 1.17 ± 0.11 | 1.48 ± 0.27 |
Arterial Po2, Torr | ||||
Con | 483 ± 25 | 536 ± 16 | 547 ± 7 | 561 ± 16 |
HF | 498 ± 30 | 497 ± 37 | 502 ± 39 | 516 ± 20 |
HF-TR | 527 ± 28 | 540 ± 25 | 521 ± 17 | 555 ± 10 |
Coronary venous Po2, Torr | ||||
Con | 25 ± 2 | 23 ± 1 | 27 ± 2 | 31 ± 4 |
HF | 22 ± 1 | 23 ± 1 | 30 ± 3 | 31 ± 3 |
HF-TR | 22 ± 1 | 23 ± 2 | 25 ± 2 | 32 ± 3 |
Coronary venous So2, % | ||||
Con | 30 ± 2 | 32 ± 1 | 39 ± 4 | 57 ± 7 |
HF | 27 ± 4 | 29 ± 3 | 38 ± 6 | 50 ± 7 |
HF-TR | 30 ± 3 | 33 ± 7 | 36 ± 7 | 49 ± 7 |
Hb, g/100 ml | ||||
Con | 8.2 ± 0.2 | 9.0 ± 0.2 | 10.1 ± 0.4 | 11.3 ± 0.8 |
HF | 9.1 ± 0.6 | 9.0 ± 0.5 | 10.8 ± 1.0 | 11.7 ± 0.9 |
HF-TR | 8.5 ± 0.5 | 8.7 ± 0.5 | 9.7 ± 0.7 | 10.6 ± 1.0 |
Values are means ± SE. MAP, mean arterial pressure; CBF, coronary blood flow; Po2, O2 pressure; So2, O2 saturation; Hb, hemoglobin.
Significance is indicated at P < 0.05 vs. Con, same pressure load.
P < 0.05 vs. Con (repeated-measures ANOVA; group main effect).